Bodycote PLC’s (BOY) Buy Rating Reaffirmed at N+1 Singer
Other research analysts have also issued research reports about the stock. Credit Suisse Group AG reaffirmed an outperform rating and set a GBX 680 ($8.50) price objective on shares of Bodycote PLC in a research report on Thursday, August 11th. Numis Securities Ltd lowered shares of Bodycote PLC to an add rating and set a GBX 655 ($8.18) price objective for the company. in a research report on Friday, July 29th. Morgan Stanley upped their price objective on shares of Bodycote PLC from GBX 680 ($8.50) to GBX 720 ($9.00) and gave the company an overweight rating in a research report on Friday, August 5th. Panmure Gordon reaffirmed a buy rating and set a GBX 685 ($8.56) price objective on shares of Bodycote PLC in a research report on Friday, July 29th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Bodycote PLC from GBX 500 ($6.25) to GBX 565 ($7.06) and gave the company an underweight rating in a research report on Friday, July 29th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock currently has a consensus rating of Buy and an average target price of GBX 660.57 ($8.25).
Bodycote PLC (LON:BOY) opened at 576.50 on Friday. The firm’s market capitalization is GBX 1.10 billion. The stock’s 50 day moving average price is GBX 600.31 and its 200 day moving average price is GBX 589.69. Bodycote PLC has a 12 month low of GBX 493.30 and a 12 month high of GBX 644.50.
About Bodycote PLC
Bodycote plc is a provider of thermal processing services. The Company has six segments, split between Aerospace, Defense and Energy (ADE) and Automotive and General Industrial (AGI) business areas: ADE-Western Europe; ADE-North America; ADE-Emerging markets; AGI-Western Europe; AGI-North America, and AGI-Emerging markets.
Receive News & Stock Ratings for Bodycote PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote PLC and related stocks with our FREE daily email newsletter.